GlassScriptPhysician profile
Gerald L Nickerson, JR.
NPI 1932127768
$6,644.09
in general payments reported to CMS, 2019-2025
32 companies · $1,796 in 2025
The $1,796 reported for 2025 was more than what 92% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $115 · 2022: $2,491 · 2023: $1,429 · 2024: $813 · 2025: $1,796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,716 · Travel and Lodging: $1,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,716.06 |
| Travel and Lodging | $1,323.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,968.52 | 2022-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Relievant Medsystems, INC. | $841.70 | 2021-2023 | Intracept |
| Nalu Medical, INC. | $752.65 | 2022 | |
| Curonix LLC | $562.04 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbvie INC. | $391.33 | 2021-2024 | |
| Vgi Medical, LLC | $310.83 | 2022 | |
| Centinel Spine, LLC | $287.97 | 2022 | |
| Vertos Medical, INC. | $276.56 | 2022-2024 | Mild Device Kit |
| Abbott Laboratories | $250.92 | 2022-2024 | Proclaim, Eterna, Ionicrf |
| Amgen INC. | $138.71 | 2022-2025 | Evenity, Prolia |
| Takeda Pharmaceuticals U.S.A., INC. | $103.36 | 2024-2025 | Hyqvia |
| Indivior INC. | $89.28 | 2023-2025 | Sublocade |
| Lilly USA, LLC | $81.97 | 2022-2024 | Taltz |
| Pfizer INC. | $64.93 | 2023-2024 | |
| Stryker Corporation | $64.23 | 2025 | Mild Device Kit |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $59.66 | 2024-2025 | Ingrezza |
| Radius Health, INC. | $51.91 | 2022-2025 | Tymlos |
| Scilex Pharmaceuticals INC. | $43.57 | 2022-2023 | Ztlido |
| Ucb, INC. | $43.46 | 2023-2024 | Cimzia |
| Si-Bone, INC. | $35.15 | 2023 | |
| Argenx US, INC. | $30.02 | 2023 | Vyvgart |
| Aurinia Pharma U.S., INC. | $29.73 | 2022 | |
| Lundbeck LLC | $27.32 | 2024 | Vyepti |
| Eisai INC. | $23.87 | 2023 | |
| Spr Therapeutics, INC | $22.22 | 2024 | Sprint Pns System |
| Alvogen INC | $17.55 | 2025 | Teriparatide |
| Janssen Biotech, INC. | $16.99 | 2022 | |
| Medtronic, INC. | $13.16 | 2024 | Kyphon Express II Kyphopak Tray |
| Sandoz INC. | $13.10 | 2023 | Hyrimoz |
| Biohaven Pharmaceutical Holding Company LTD. | $13.09 | 2022 | |
| Stimwave Technologies Incorporated | $12.84 | 2022 | |
| Merit Medical Systems INC | $5.45 | 2024 | Stabilit System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Nickerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.